Buprenorphine Compounded Buccal Solution, Veterinary
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Buprenorphine Compounded Buccal Solution, Veterinary, contains NLT 90.0% and NMT 110.0% of the labeled amount of buprenorphine (C₂₉H₄₁NO₄).
Prepare Buprenorphine Compounded Buccal Solution, Veterinary 3 mg/mL as follows (see Pharmaceutical Compounding—Nonsterile Preparations 〈795〉).
Buprenorphine (as hydrochloride) 30 mg (32.4 mg)
Dextrose 500 mg
Sodium Citrate (anhydrous) 20 mg
Citric Acid Monohydrate 25 mg
Purified Water, a sufficient quantity to make 10 mL
Dissolve the Dextrose, Sodium Citrate Anhydrous, and Citric Acid Monohydrate in 5 mL of Purified Water in a suitable calibrated container. Add the Buprenorphine hydrochloride powder into the mixture and add sufficient Purified Water to bring to final volume, and mix well.
2 ASSAY
Procedure
Mobile phase: Acetonitrile and 10 mM ammonium acetate (80:20)
Standard solution: 0.3 mg/mL of buprenorphine prepared from USP Buprenorphine Hydrochloride RS in methanol
Sample solution: Transfer 1 mL of Buccal Solution, Veterinary into a 10-mL volumetric flask, dilute with methanol to volume, and mix well.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 280 nm
Column: 2.1-mm × 5-cm; 5-µm packing L7
Column temperature: 40°
Flow rate: 0.25 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
[Note—The retention time for buprenorphine is about 5.8 min.]
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0% for replicate injections
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of buprenorphine (C₂₉H₄₁NO₄) in the portion of Buccal Solution, Veterinary taken:
Result = (r₁/r₂) × (C₁/C₂) × 100
r₁ = peak response of buprenorphine from the Sample solution
r₂ = peak response of buprenorphine from the Standard solution
C₁ = concentration of buprenorphine in the Standard solution (mg/mL)
C₂ = nominal concentration of buprenorphine in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
3 SPECIFIC TESTS
pH 〈791〉: 3.5–4.5
4 ADDITIONAL REQUIREMENTS
Packaging and Storage: Package in tight, light-resistant containers. Store at 2°–8°.
Labeling: Label it to indicate that it is for veterinary use only. Label to indicate that it is for buccal administration, and to state the Beyond-Use Date.
Beyond-Use Date: NMT 90 days after the date on which it was compounded when stored at 2°–8°
USP Reference Standards 〈11〉
USP Buprenorphine Hydrochloride RS

